Complement C3
| GO Term | Evidence Code | Reference |
|---|---|---|
| positive regulation of type IIa hypersensitivity |
|
|
| complement activation, lectin pathway | ||
| positive regulation of protein phosphorylation | ||
| positive regulation of activation of membrane attack complex | ||
| complement receptor mediated signaling pathway |
| GO Term | Evidence Code | Reference |
|---|---|---|
| classical-complement-pathway C3/C5 convertase complex | ||
| obsolete extracellular space |
|
|
| cell surface | ||
| cell surface | ||
| symbiont cell surface |
| GO Term | Evidence Code | Reference |
|---|---|---|
| antigen binding | ||
| endopeptidase inhibitor activity | ||
| C5L2 anaphylatoxin chemotactic receptor binding | ||
| C5L2 anaphylatoxin chemotactic receptor binding | ||
| receptor ligand activity |
| Pathway Name | Organism |
|---|---|
| Activation of C3 and C5 | Bos taurus |
| Alternative complement activation | Bos taurus |
| G alpha (i) signalling events | Bos taurus |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | Bos taurus |
| Neutrophil degranulation | Bos taurus |
| Peptide ligand-binding receptors | Bos taurus |
| Post-translational protein phosphorylation | Bos taurus |
| Regulation of Complement cascade | Bos taurus |
| Regulation of IGF Activity by IGFBP | Bos taurus |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026